Hepatitis C Virus II

Infection and Disease

  • Tatsuo Miyamura
  • Stanley M. Lemon
  • Christopher M. Walker
  • Takaji Wakita

Table of contents

  1. Front Matter
    Pages i-ix
  2. Chronic Hepatitis C

    1. Front Matter
      Pages 1-1
    2. Marc G. Ghany, T. Jake Liang
      Pages 3-55
    3. Melissa A. Sheiko, Hugo R. Rosen
      Pages 79-108
    4. Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen
      Pages 109-136
    5. Terence N. Bukong, Banishree Saha, Gyongyi Szabo
      Pages 137-163
    6. Wen-Chi Su, Keigo Machida, Michael M. C. Lai
      Pages 165-184
  3. HCV Infections in Special Populations

    1. Front Matter
      Pages 185-185
    2. Jessica Wen, Samantha Ohmer, Jonathan Honegger
      Pages 187-222
  4. Approaches to Therapy

    1. Front Matter
      Pages 223-223
    2. Yasuhito Tanaka, Masashi Mizokami
      Pages 225-241
    3. Shinya Maekawa, Nobuyuki Enomoto
      Pages 243-256
    4. Nicolas Tremblay, Alex Young Park, Daniel Lamarre
      Pages 257-285
    5. Piero Colombatto, Ferruccio Bonino, Luigi Civitano, Filippo Oliveri, Gabriele Ricco, Sergio Iannazzo et al.
      Pages 303-321
  5. Prevention and Control of HCV Infection

    1. Front Matter
      Pages 323-323
    2. Tatsuo Miyamura
      Pages 347-368
  6. Back Matter
    Pages 369-372

About this book

Introduction

This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future. It covers many basic aspects of the pathogenesis of chronic hepatitis C, HCV infections in particular populations, approaches to therapy, and prevention and control of HCV Infection. The book provides a succinct review of the large amount of data generated by multiple groups over the past two decades that has revealed the natural history of HCV infection. Similarly, it summarizes current understanding of the origins of HCV-associated hepatocellular carcinoma, cirrhosis and hepatic fibrosis. Extra-hepatic manifestation and metabolic disorders related to HCV infection are described. In this volume, these clinically important aspects of HCV infection are comprehensively described. Highlights are description of newly developed direct- acting antivirals. The authors represent a worldwide distribution of leaders in the field reflecting the global nature of HCV infection. Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.

Keywords

Chronic Hepatitis HCV Infection Therapy Vaccines

Editors and affiliations

  • Tatsuo Miyamura
    • 1
  • Stanley M. Lemon
    • 2
  • Christopher M. Walker
    • 3
  • Takaji Wakita
    • 4
  1. 1.National Institute of Infectious Disease TokyoJapan
  2. 2.Departments of Medicine and MicrobiologyThe Univ of N Carolina at Chapel Hill Departments of Medicine and MicrobiologyChapel HillUSA
  3. 3.Center for Vaccines and ImmunityThe Research Institute at Nationwide Children's Hospital OhioUSA
  4. 4.National Institute of Infectious DiseaseTokyoJapan

Bibliographic information

  • DOI https://doi.org/10.1007/978-4-431-56101-9
  • Copyright Information Springer Japan 2016
  • Publisher Name Springer, Tokyo
  • eBook Packages Medicine
  • Print ISBN 978-4-431-56099-9
  • Online ISBN 978-4-431-56101-9
  • About this book
Industry Sectors
Biotechnology
Pharma